Disclosed positions

Estimated from their latest filings — positions may have changed since

$1.55M

combined est. value

Stock	Shares	Price	Value	Weight	As of
ADPTAdaptive Biotechnologies Corp	46,722	$20.16	$941.9K	61%	2025-12-10
RXRXRECURSION PHARMACEUTICALS, INC.	162,156	$3.72	$603.2K	39%	2026-06-17

ADPT

Adaptive Biotechnologies Corp

$941.9K

46,722 sh

RXRX

RECURSION PHARMACEUTICALS, INC.

$603.2K

162,156 sh

All filings on record

Every Form 4 transaction we track for this filer

all 4buys 0sells 1

Stock	Transaction	Date	~6mo later
RXRXRECURSION PHARMACEUTICALS, INC.	Grant — · 88,424 sh	2026-06-17	—
ADPTAdaptive Biotechnologies Corp	Sell $367.5K · 22,968 sh	2025-12-10	—
HLVXHilleVax, Inc.	Other — · 1,101,498 sh	2025-09-17	—
RXRXRECURSION PHARMACEUTICALS, INC.	Grant — · 22,016 sh	2025-06-18	—

RXRXGrant

2026-06-17 · RECURSION PHARMACEUTICALS, INC.

88,424

—

ADPTSell

2025-12-10 · Adaptive Biotechnologies Corp

$367.5K

—

HLVXOther

2025-09-17 · HilleVax, Inc.

1,101,498

—

RXRXGrant

2025-06-18 · RECURSION PHARMACEUTICALS, INC.

22,016

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.